Page last updated: 2024-08-25

selfotel and Arterial Occlusive Diseases

selfotel has been researched along with Arterial Occlusive Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abou-Gharbia, M; Baudy, RB; Bramlett, DR; Fletcher, H; Katz, AH; Kowal, DM; Moyer, JA; Tasse, RP; Yardley, JP; Zaleska, MM1
Haapalinna, A; Jolkkonen, J; Kauppinen, R; Koistinaho, J; Nieminen, L; Puurunen, K; Sivenius, J1
Choi, DW; Zivin, JA1

Trials

1 trial(s) available for selfotel and Arterial Occlusive Diseases

ArticleYear
Stroke therapy.
    Scientific American, 1991, Volume: 265, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Calcium; Cell Survival; Cerebral Arterial Diseases; Cerebrovascular Disorders; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Humans; Intracranial Embolism and Thrombosis; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Tissue Plasminogen Activator; Tomography, Emission-Computed

1991

Other Studies

2 other study(ies) available for selfotel and Arterial Occlusive Diseases

ArticleYear
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Journal of medicinal chemistry, 2001, May-10, Volume: 44, Issue:10

    Topics: Animals; Arterial Occlusive Diseases; Benzimidazoles; Binding, Competitive; Brain; Carotid Artery Diseases; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; In Vitro Techniques; Infarction, Middle Cerebral Artery; Male; Mice; Models, Molecular; Neuroprotective Agents; Organophosphonates; Propionates; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate; Stereoisomerism

2001
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
    European journal of pharmacology, 1999, May-07, Volume: 372, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Arterial Occlusive Diseases; Body Weight; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Excitatory Amino Acid Antagonists; Imidazoles; Ischemic Attack, Transient; Male; Medetomidine; Neuroprotective Agents; Pipecolic Acids; Quinoxalines; Rats; Rats, Wistar

1999